Evidence map›Paper›PMID 38013969›Full record

ArticleClinical immunology communications2022

Memory T cell responses in seronegative older adults following SARS-CoV-2 vaccination.

Merve Hafızoğlu, Arzu Okyar Bas, Ece Tavukçuoğlu, Zeynep Sahiner, Merve Güner Oytun, Sıla Ulutürk, Hamdullah Yanık, Burcu Balam Doğu, Mustafa Cankurtaran, Güneş Esendağlı and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical immunology communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Considerations on COVID-19 vaccination.Clinical immunology communications · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Merve HafızoğluDepartment of Internal Medicine, Division of Geriatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Arzu Okyar BasDepartment of Internal Medicine, Division of Geriatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Ece TavukçuoğluDepartment of Basic Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.
Zeynep SahinerDepartment of Internal Medicine, Division of Geriatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Merve Güner OytunDepartment of Internal Medicine, Division of Geriatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Sıla UlutürkDepartment of Basic Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.
Hamdullah YanıkDepartment of Basic Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.
Burcu Balam DoğuDepartment of Internal Medicine, Division of Geriatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Mustafa CankurtaranDepartment of Internal Medicine, Division of Geriatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Güneş EsendağlıDepartment of Basic Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.
Filiz AkbıyıkAnkara City Hospital Siemens Healthineers Laboratory, Enterprise Services & Solutions, Ankara, Turkey.
Banu ÇakırDepartment of Public Health, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Serhat ÜnalDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Meltem Gülhan HalilDepartment of Internal Medicine, Division of Geriatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Generating memory T cell responses besides humoral immune responses is essential when it comes to the efficacy of a vaccine. In this study, the presence of memory T cell responses after aluminum-adjuvanted inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac) in seronegative and seropositive elderly individuals were examined. CD4

Indexed as

COVID-19Memory T cell responsesVaccine

Identifiers

PMID38013969
PMCPMC9529214

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.